Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study)
| العنوان: | Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study) |
|---|---|
| المؤلفون: | Yasushi Tanaka, Ryusuke Koshida, Masayuki Senda, Takahisa Hirose, Yasuo Terauchi, Masato Odawara, Munehide Matsuhisa |
| المصدر: | Expert Opinion on Pharmacotherapy. 22:249-256 |
| بيانات النشر: | Informa UK Limited, 2020. |
| سنة النشر: | 2020 |
| مصطلحات موضوعية: | Adult, Blood Glucose, Male, Pediatrics, medicine.medical_specialty, endocrine system diseases, Insulin Glargine, Postmarketing surveillance, 03 medical and health sciences, 0302 clinical medicine, Japan, Product Surveillance, Postmarketing, Humans, Hypoglycemic Agents, Medicine, Basal insulin, Pharmacology (medical), Prospective Studies, Aged, Glycated Hemoglobin, Pharmacology, Type 1 diabetes, Dose-Response Relationship, Drug, business.industry, Insulin glargine, nutritional and metabolic diseases, General Medicine, Middle Aged, medicine.disease, Hypoglycemia, post-marketing surveillance study, Diabetes Mellitus, Type 1, 030220 oncology & carcinogenesis, Japanese, Female, business, Real world data, type 1 diabetes mellitus, 030217 neurology & neurosurgery, medicine.drug |
| الوصف: | Background: With limited real-world insulin glargine 300 U/mL (Gla-300) data among Japanese patients with type 1 diabetes mellitus (T1DM) available, the authors describe its effectiveness and safety in Japanese T1DM patients switching to Gla-300. Research design and methods: X-STAR was a 12-month prospective, observational, post-marketing study in Japanese patients with diabetes mellitus from 2015 to 2018: insulin-experienced T1DM patients initiating Gla-300 were analyzed. Results: Of 774 patients, mean (±standard deviation) HbA1c (%) and fasting plasma glucose (mg/dL) decreased from 8.27 ± 1.55 to 8.15 ± 1.35 (by −0.12 ± 1.30 [p = 0.013]) and 167.9 ± 92.6 to 153.9 ± 70.9 (by −13.9 ± 103.8 [p = 0.067]) from baseline to month 12, respectively. A total of 16.3% achieved HbA1c |
| وصف الملف: | application/pdf |
| تدمد: | 1744-7666 1465-6566 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6aff7d63443b8c7dbb8d5932dbbdb0Test https://doi.org/10.1080/14656566.2020.1810665Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....fa6aff7d63443b8c7dbb8d5932dbbdb0 |
| قاعدة البيانات: | OpenAIRE |
| ResultId |
1 |
|---|---|
| Header |
edsair OpenAIRE edsair.doi.dedup.....fa6aff7d63443b8c7dbb8d5932dbbdb0 874 3 unknown 874.43701171875 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fa6aff7d63443b8c7dbb8d5932dbbdb0&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
|
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study)
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Yasushi+Tanaka%22">Yasushi Tanaka</searchLink><br /><searchLink fieldCode="AR" term="%22Ryusuke+Koshida%22">Ryusuke Koshida</searchLink><br /><searchLink fieldCode="AR" term="%22Masayuki+Senda%22">Masayuki Senda</searchLink><br /><searchLink fieldCode="AR" term="%22Takahisa+Hirose%22">Takahisa Hirose</searchLink><br /><searchLink fieldCode="AR" term="%22Yasuo+Terauchi%22">Yasuo Terauchi</searchLink><br /><searchLink fieldCode="AR" term="%22Masato+Odawara%22">Masato Odawara</searchLink><br /><searchLink fieldCode="AR" term="%22Munehide+Matsuhisa%22">Munehide Matsuhisa</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <i>Expert Opinion on Pharmacotherapy</i>. 22:249-256 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Informa UK Limited, 2020. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2020 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Blood+Glucose%22">Blood Glucose</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Pediatrics%22">Pediatrics</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22endocrine+system+diseases%22">endocrine system diseases</searchLink><br /><searchLink fieldCode="DE" term="%22Insulin+Glargine%22">Insulin Glargine</searchLink><br /><searchLink fieldCode="DE" term="%22Postmarketing+surveillance%22">Postmarketing surveillance</searchLink><br /><searchLink fieldCode="DE" term="%2203+medical+and+health+sciences%22">03 medical and health sciences</searchLink><br /><searchLink fieldCode="DE" term="%220302+clinical+medicine%22">0302 clinical medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Japan%22">Japan</searchLink><br /><searchLink fieldCode="DE" term="%22Product+Surveillance%2C+Postmarketing%22">Product Surveillance, Postmarketing</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Hypoglycemic+Agents%22">Hypoglycemic Agents</searchLink><br /><searchLink fieldCode="DE" term="%22Medicine%22">Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Basal+insulin%22">Basal insulin</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmacology+%28medical%29%22">Pharmacology (medical)</searchLink><br /><searchLink fieldCode="DE" term="%22Prospective+Studies%22">Prospective Studies</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Glycated+Hemoglobin%22">Glycated Hemoglobin</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmacology%22">Pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22Type+1+diabetes%22">Type 1 diabetes</searchLink><br /><searchLink fieldCode="DE" term="%22Dose-Response+Relationship%2C+Drug%22">Dose-Response Relationship, Drug</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22Insulin+glargine%22">Insulin glargine</searchLink><br /><searchLink fieldCode="DE" term="%22nutritional+and+metabolic+diseases%22">nutritional and metabolic diseases</searchLink><br /><searchLink fieldCode="DE" term="%22General+Medicine%22">General Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edisease%22">medicine.disease</searchLink><br /><searchLink fieldCode="DE" term="%22Hypoglycemia%22">Hypoglycemia</searchLink><br /><searchLink fieldCode="DE" term="%22post-marketing+surveillance+study%22">post-marketing surveillance study</searchLink><br /><searchLink fieldCode="DE" term="%22Diabetes+Mellitus%2C+Type+1%22">Diabetes Mellitus, Type 1</searchLink><br /><searchLink fieldCode="DE" term="%22030220+oncology+%26+carcinogenesis%22">030220 oncology & carcinogenesis</searchLink><br /><searchLink fieldCode="DE" term="%22Japanese%22">Japanese</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink><br /><searchLink fieldCode="DE" term="%22Real+world+data%22">Real world data</searchLink><br /><searchLink fieldCode="DE" term="%22type+1+diabetes+mellitus%22">type 1 diabetes mellitus</searchLink><br /><searchLink fieldCode="DE" term="%22030217+neurology+%26+neurosurgery%22">030217 neurology & neurosurgery</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edrug%22">medicine.drug</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Background: With limited real-world insulin glargine 300 U/mL (Gla-300) data among Japanese patients with type 1 diabetes mellitus (T1DM) available, the authors describe its effectiveness and safety in Japanese T1DM patients switching to Gla-300. Research design and methods: X-STAR was a 12-month prospective, observational, post-marketing study in Japanese patients with diabetes mellitus from 2015 to 2018: insulin-experienced T1DM patients initiating Gla-300 were analyzed. Results: Of 774 patients, mean (±standard deviation) HbA1c (%) and fasting plasma glucose (mg/dL) decreased from 8.27 ± 1.55 to 8.15 ± 1.35 (by −0.12 ± 1.30 [p = 0.013]) and 167.9 ± 92.6 to 153.9 ± 70.9 (by −13.9 ± 103.8 [p = 0.067]) from baseline to month 12, respectively. A total of 16.3% achieved HbA1c ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1744-7666<br />1465-6566 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6aff7d63443b8c7dbb8d5932dbbdb0" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa6aff7d63443b8c7dbb8d5932dbbdb0</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.1080/14656566.2020.1810665" linkWindow="_blank">https://doi.org/10.1080/14656566.2020.1810665</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....fa6aff7d63443b8c7dbb8d5932dbbdb0 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => Undetermined
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 8
[StartPage] => 249
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Adult
[Type] => general
)
[1] => Array
(
[SubjectFull] => Blood Glucose
[Type] => general
)
[2] => Array
(
[SubjectFull] => Male
[Type] => general
)
[3] => Array
(
[SubjectFull] => Pediatrics
[Type] => general
)
[4] => Array
(
[SubjectFull] => medicine.medical_specialty
[Type] => general
)
[5] => Array
(
[SubjectFull] => endocrine system diseases
[Type] => general
)
[6] => Array
(
[SubjectFull] => Insulin Glargine
[Type] => general
)
[7] => Array
(
[SubjectFull] => Postmarketing surveillance
[Type] => general
)
[8] => Array
(
[SubjectFull] => 03 medical and health sciences
[Type] => general
)
[9] => Array
(
[SubjectFull] => 0302 clinical medicine
[Type] => general
)
[10] => Array
(
[SubjectFull] => Japan
[Type] => general
)
[11] => Array
(
[SubjectFull] => Product Surveillance, Postmarketing
[Type] => general
)
[12] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[13] => Array
(
[SubjectFull] => Hypoglycemic Agents
[Type] => general
)
[14] => Array
(
[SubjectFull] => Medicine
[Type] => general
)
[15] => Array
(
[SubjectFull] => Basal insulin
[Type] => general
)
[16] => Array
(
[SubjectFull] => Pharmacology (medical)
[Type] => general
)
[17] => Array
(
[SubjectFull] => Prospective Studies
[Type] => general
)
[18] => Array
(
[SubjectFull] => Aged
[Type] => general
)
[19] => Array
(
[SubjectFull] => Glycated Hemoglobin
[Type] => general
)
[20] => Array
(
[SubjectFull] => Pharmacology
[Type] => general
)
[21] => Array
(
[SubjectFull] => Type 1 diabetes
[Type] => general
)
[22] => Array
(
[SubjectFull] => Dose-Response Relationship, Drug
[Type] => general
)
[23] => Array
(
[SubjectFull] => business.industry
[Type] => general
)
[24] => Array
(
[SubjectFull] => Insulin glargine
[Type] => general
)
[25] => Array
(
[SubjectFull] => nutritional and metabolic diseases
[Type] => general
)
[26] => Array
(
[SubjectFull] => General Medicine
[Type] => general
)
[27] => Array
(
[SubjectFull] => Middle Aged
[Type] => general
)
[28] => Array
(
[SubjectFull] => medicine.disease
[Type] => general
)
[29] => Array
(
[SubjectFull] => Hypoglycemia
[Type] => general
)
[30] => Array
(
[SubjectFull] => post-marketing surveillance study
[Type] => general
)
[31] => Array
(
[SubjectFull] => Diabetes Mellitus, Type 1
[Type] => general
)
[32] => Array
(
[SubjectFull] => 030220 oncology & carcinogenesis
[Type] => general
)
[33] => Array
(
[SubjectFull] => Japanese
[Type] => general
)
[34] => Array
(
[SubjectFull] => Female
[Type] => general
)
[35] => Array
(
[SubjectFull] => business
[Type] => general
)
[36] => Array
(
[SubjectFull] => Real world data
[Type] => general
)
[37] => Array
(
[SubjectFull] => type 1 diabetes mellitus
[Type] => general
)
[38] => Array
(
[SubjectFull] => 030217 neurology & neurosurgery
[Type] => general
)
[39] => Array
(
[SubjectFull] => medicine.drug
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study)
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yasushi Tanaka
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ryusuke Koshida
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Masayuki Senda
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Takahisa Hirose
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yasuo Terauchi
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Masato Odawara
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Munehide Matsuhisa
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 25
[M] => 08
[Type] => published
[Y] => 2020
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 17447666
)
[1] => Array
(
[Type] => issn-print
[Value] => 14656566
)
[2] => Array
(
[Type] => issn-locals
[Value] => edsair
)
[3] => Array
(
[Type] => issn-locals
[Value] => edsairFT
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 22
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Expert Opinion on Pharmacotherapy
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |